ArticleCell death & disease2026

RIP kinase inhibition with Necrostatin-1 improves human marginal mass islet graft survival and function for the management of type 1 diabetes.

Saloni Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.